Active Biotech completes rights offering

Active Biotech AB (SSE:ACTI), Lund, Sweden Business: Cancer, Autoimmune Date completed: 6/15/09 Type: Rights offering Raised: SEK256.2 million ($32.7 million) Shares: 12.8 million Price: SEK20 Shares ...